Renal adverse effects of nonsteroidal anti-inflammatory drugs.
about
Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacistsE-type prostanoid receptor 4 (EP4) in disease and therapyFrom Pre-Existing Renal Failure to Perioperative Renal Protection: The Anesthesiologist's DilemmasNonsteroidal Anti-Inflammatory Drugs and the KidneyPure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome.Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis.Dipyrone & 2,5-dimethylcelecoxib suppress Th2-related chemokine production in monocyte.Prevalence and concomitants of arthritis in the elderly in Rio Grande do Sul, Brazil.NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011.A high-throughput three-dimensional cell migration assay for toxicity screening with mobile device-based macroscopic image analysis.Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitorsExacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.Diclofenac sodium topical solution with dimethyl sulfoxide, a viable alternative to oral nonsteroidal anti-inflammatories in osteoarthritis: review of current evidence.Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats.NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip.Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older.Effects of lornoxicam and intravenous ibuprofen on erythrocyte deformability and hepatic and renal blood flow in rats.Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.Gout-related inpatient utilization: a study of predictors of outcomes and time trends.Anorexia nervosa and dialysis: we have no time when the body is so damaged!Evaluation of anti-inflammatory activity of selected medicinal plants used in Indian traditional medication system in vitro as well as in vivo.Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety.The NSAID dilemma: managing osteoarthritis in high-risk patients.Towards developing new strategies to reduce the adverse side-effects of nonsteroidal anti-inflammatory drugs.Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels.Pharmacogenetics of nonsteroidal anti-inflammatory drugs.Adverse drug events as a cause of hospitalization in older adults.Recent management advances in acute postoperative pain.Drug-induced hyperkalemia.The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspective.Renal involvement in mushroom poisoning: The case of Orellanus syndrome.Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation.Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.Inhibitory effect of hot-water extract of quince (Cydonia oblonga) on immunoglobulin E-dependent late-phase immune reactions of mast cells.A simple high performance liquid chromatography method for determination of rebamipide in rat urine.Changes in pain and concurrent pain medication use following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational Optimizing Patient Experience and Response to Topical AnalgesiTraumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries.
P2860
Q24631134-80EFA6FE-3F6D-4B87-BE7A-C1FF89C9F55BQ26851156-6C3B25FC-39EE-4431-BD05-68B0E504A2F7Q28075283-A3F20606-A56A-4BE1-AA80-2383B39B0424Q28386844-CF5B7357-5E65-4405-A45D-B9B6AFE02756Q33426042-5C89FD1B-A9B0-47CE-BA45-6AF69ACE42B6Q33871754-865EB863-BA14-4F6D-BC8C-591A9502A7F0Q34272055-17965FF5-19B5-4C0D-BD0D-CBA673FB2ADAQ34428989-8F5B2F50-E930-45FD-AFA6-37DF3A5479F5Q34754712-78047CF0-F361-4A7E-9839-82CCBAE6C2C7Q35021224-55779429-9AB4-4D72-9595-CA027ED0386BQ35089858-0F6C5624-922B-433A-91BA-4ACC91C2BBB4Q35106649-7E5DD50B-6A89-4B3C-990D-6171E758145DQ35122695-9BBA9F24-4BDD-47ED-8440-3AFC73689823Q35448046-4DAF9CE9-B3AE-44E4-A81C-437878214220Q35814520-B73D3278-D412-4C86-963A-A1E3870C9398Q35827119-67E1CAB1-0157-4ECB-8BC5-9569F34EE792Q36086215-A157734E-F638-4411-BA60-6681DF32D725Q36106476-6FFC747E-5634-4355-A24A-551308E1E044Q36233306-4EC108C2-3F1F-4594-883B-70FF418AB90BQ36639088-BD265051-B7DA-4702-8317-1501B94FEA61Q36704595-3813F605-8852-4A78-A2A1-A8DA33F8D329Q37346062-5E5F3F90-65FF-4604-88D9-22E70DEB797FQ37900831-E7BDB7CD-5E63-4303-81FB-BB882470C799Q37949849-5A05272B-D832-43EB-B7EE-F72F82557293Q37950890-12BD115F-CEAB-4742-A74F-2BA15FE8DD77Q38040134-68F46B09-8068-4936-8421-203E8AB9D5B7Q38050316-DC0BB3E3-0E93-40ED-BF42-91CBBE907F18Q38085222-9C91098D-4418-4603-9888-BB8D65D81BF5Q38128923-51BAEB08-09C1-4132-BD00-0BF1EF2FC24BQ38232308-51248FF3-2CC3-41B3-A708-2C434259783FQ38290838-61227E13-6A45-4FF8-A97B-D3E224A2C116Q38316845-4588E5B8-B8D4-4AD3-8442-9AE4A3AF3B0FQ38343483-1BC6C203-CCFD-46C9-A063-43FACC7460F1Q38447864-7185021F-8A9B-4794-B338-00D87CD190E6Q38725462-64A3F260-AAD5-475C-8679-576074AD8DAFQ39449789-866DADF2-A6E8-417D-BEAC-D5D2ADB43DE0Q41785020-4EE09B3A-132F-4B25-BF6D-3D3348824C97Q41905852-6E50B038-2714-41A0-9FD0-73080C74C005Q42373815-4099CA77-4AAA-4F1E-AE4F-AAA5EB21EA98Q42724656-981E463F-4D5E-47F7-95C1-C0ECB569E5BF
P2860
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@en
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@nl
type
label
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@en
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@nl
prefLabel
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@en
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@nl
P2860
P1476
Renal adverse effects of nonsteroidal anti-inflammatory drugs.
@en
P2093
Fakhreddin Jamali
Sam Harirforoosh
P2860
P304
P356
10.1517/14740330903311023
P407
P577
2009-11-01T00:00:00Z